FDA psychedelics
FDA Grants MindMed’s LSD Formulation Breakthrough Designation
Optimi Health Obtains Permit to Increase MDMA Production
Cybin: Psilocybin Trial Participants Experience Nearly 80% Reduction in Depression Symptoms
Beckley Psytech Secures $50 Million Investment from atai to Advance Short-Duration Psychedelic Therapies
Navigating the Psychedelic Renaissance: The Intersection of Medicine, Spirituality and Big Business
1 2